News & Analysis as of November 19, 2024

Biosimilars

+ Follow

Podcast: IP Life Sciences Landscape: Aiding Orange and Purple Book Patent Owners in Developing PTAB Survival Skills

Venable’s BiologicsHQ Monthly Injection - October 2024

Venable LLP on 11/11/2024

Welcome to Venable’s BiologicsHQ Monthly Injection – October 2024...more

Venable’s BiologicsHQ Monthly Injection - August 2024

Venable LLP on 8/27/2024

Welcome to Venable’s BiologicsHQ Monthly Injection – August 2024...more

Venable’s BiologicsHQ Monthly Injection - July 2024

Venable LLP on 7/10/2024

Welcome to Venable’s BiologicsHQ Monthly Injection – July 2024...more

[Webinar] 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA - October 10th - 26th, 1:00 pm EST

American Conference Institute (ACI) on 9/13/2023

Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials, a critical competency for legal and business professionals in the biopharmaceutical arena. Attend ACI’s Hatch-Waxman and BPCIA Proficiency Series...more

The Name Game Continues: AbbVie Files Supplemental Citizen Petition Raising Additional Concerns Regarding Biosimilar Labeling

K&L Gates LLP on 9/2/2015

AbbVie previously filed a citizen petition to the FDA arguing against its interim labeling requirements for biosimilars under the Biologics Price Competition and Innovation Act (“BPCIA”). In its supplemental petition, AbbVie...more

5 Results

View per page